| Last Price | Today's Change | 52-Week Range | Trading Volume |
|---|---|---|---|
| 0.57 | 0.00 (0.00%) | 0.35 - 1.47 | 5.2 thousand (Below Avg) |
Market data as of 3:56PM 06/19/13. Quotes are delayed by at least 15 min.
| Open | 0.57 |
|---|---|
| Previous Close | 0.57 |
| Day's Range | 0.57 - 0.57 |
| Market Cap | 19.7M |
| Avg Volume (10 Day) | 44.3K |
| Price/Earnings (Trailing 12 Mo.) | -- |
| Earnings Per Share (Trailing 12 Mo.) | -0.12 |
| Dividend Yield | No Dividend |


These seven metrics are a snap to calculate, thanks to Quicken.com's One-Click Scorecard. Our goal with this tool is to help you evaluate potential investment candidates and eliminate those equities that aren't up to snuff. One-Click Scorecard won't do all the homework necessary for you to reach a decision, but it will help you develop a list of quality stocks to watch and study further.
| Performed well consistently? | Fail |
|---|---|
| Avoids excess debt? | Fail |
| Converting sales to profits? | Fail |
| Shareholder's money handled rationally? | Neutral |
| Increased shareholder value? | Neutral |
| Consistently increased owner earnings? | Fail |
| Sells at 25% discount to intrinsic value? | Fail |


These eight metrics are a snap to calculate, thanks to Quicken.com's One-Click Scorecard. Our goal with this tool is to help you evaluate potential investment candidates and eliminate those equities that aren't up to snuff. One-Click Scorecard won't do all the homework necessary for you to reach a decision, but it will help you develop a list of quality stocks to watch and study further.
| Pays a cash dividend? | Neutral |
|---|---|
| Room to increase dividends? | Fail |
| Increased earnings over time? | Neutral |
| Borrows within reasonable limits? | Pass |
| Stock is undervalued? | Fail |
| Have investors caught on? | Fail |
| Has support of institutional investors? | Fail |
| Has sufficient liquidity? | Pass |
IsoRay Announces A New International Distributor For Greece
PR Newswire - Tuesday 05/21/2013 9:15 AM ET
| ISR | Industry Range | |
|---|---|---|
| Revenue Growth (1yr) | -8.39% | |
| Net Income Growth (1yr) | -- | |
| Total Debt/Equity | 0.00 | |
| LT Debt/Equity | 0.00 | |
| Earnings Yield | -- | |
| Price/Sales | 4.29 |
| Company | Last | Change |
|---|---|---|
| CAS Medical Systems Inc | 1.67 | -1.76% |
| Oculus Innovative Sciences Inc | 3.00 | -0.33% |
| Lakeland Industries Inc | 4.84 | +0.99% |
| Kips Bay Medical Inc | 1.02 | -1.92% |
| Daxor Corp | 7.30 | 0.00% |
Data is delayed by at least 15 min.